Study on antipruritic action of Neurotropin injection in humectant and antihistamine drug treatment-resistant patients with dermal pruritus

Study on antipruritic action of Neurotropin injection in humectant and antihistamine drug treatment-resistant patients with dermal pruritus - Study on antipruritic action of Neurotropin injection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021318

Enrollment

Registered

2016-03-03

Start date

2016-03-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dermal pruritus

Interventions

Study on antipruritic action of Neurotropin injection in humectant and antihistamine drug treatment-resistant patients with dermal pruritus Before a week, eight week treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Pruritis patient 2)Over 20-years-old 3)treatment of pruritis over a week 4)pruritic grade 2>= 5)agreement for this study 6)possible writing of pruritic daily

Exclusion criteria

Exclusion criteria: 1)allergy for Neurotropin 2)other effective drug treatment for pruritis 3)patient of feed, pregnancy, or possible of pregnancy 4)impossible regularly consultation 5)heavy disease of heart, liver, or kidney 6)ohter impossible patient

Design outcomes

Primary

Measure	Time frame
Sift of Shiratori's grade in pruritus severity during 7 weeks' intervention	—

Countries

Japan

Contacts

Public ContactSakae Kaneko

Shimane University Hospital Dermatology

kanekos2@med.shimane-u.ac.jp0853-20-2210

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026